WCN24-1865 LONG-TERM IMMUNOGENICITY AND EFFICACY OF RECOMBINANT ChAdOx1 nCoV- 19 CORONA VIRUS VACCINE (COVISHIELD) IN PATIENTS ON HEMODIALYSIS – A PROSPECTIVE, 1-YEAR FOLLOW-UP COHORT STUDY
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924005187 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849690990438252544 |
|---|---|
| author | Aarthi Muthukumaran Jayalakshmi Seshadri Raman Swaminathan Mallika Ravindran |
| author_facet | Aarthi Muthukumaran Jayalakshmi Seshadri Raman Swaminathan Mallika Ravindran |
| author_sort | Aarthi Muthukumaran |
| collection | DOAJ |
| format | Article |
| id | doaj-art-72847cc2a4e347cb8d8cf4161df84b34 |
| institution | DOAJ |
| issn | 2468-0249 |
| language | English |
| publishDate | 2024-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj-art-72847cc2a4e347cb8d8cf4161df84b342025-08-20T03:21:10ZengElsevierKidney International Reports2468-02492024-04-0194S21010.1016/j.ekir.2024.02.429WCN24-1865 LONG-TERM IMMUNOGENICITY AND EFFICACY OF RECOMBINANT ChAdOx1 nCoV- 19 CORONA VIRUS VACCINE (COVISHIELD) IN PATIENTS ON HEMODIALYSIS – A PROSPECTIVE, 1-YEAR FOLLOW-UP COHORT STUDYAarthi Muthukumaran0Jayalakshmi Seshadri1Raman Swaminathan2Mallika Ravindran3London, Renal Medicine, United KingdomInstitute of Nephrology, Madras Medical College and Rajiv Gandhi Government General Hospital, ChennaiMedical Oncology, Madras Cancer Care Foundation and Apollo Speciality Hospital, ChennaiBiochemistry, Anderson Diagnostics and Services Private Limited, Chennaihttp://www.sciencedirect.com/science/article/pii/S2468024924005187 |
| spellingShingle | Aarthi Muthukumaran Jayalakshmi Seshadri Raman Swaminathan Mallika Ravindran WCN24-1865 LONG-TERM IMMUNOGENICITY AND EFFICACY OF RECOMBINANT ChAdOx1 nCoV- 19 CORONA VIRUS VACCINE (COVISHIELD) IN PATIENTS ON HEMODIALYSIS – A PROSPECTIVE, 1-YEAR FOLLOW-UP COHORT STUDY Kidney International Reports |
| title | WCN24-1865 LONG-TERM IMMUNOGENICITY AND EFFICACY OF RECOMBINANT ChAdOx1 nCoV- 19 CORONA VIRUS VACCINE (COVISHIELD) IN PATIENTS ON HEMODIALYSIS – A PROSPECTIVE, 1-YEAR FOLLOW-UP COHORT STUDY |
| title_full | WCN24-1865 LONG-TERM IMMUNOGENICITY AND EFFICACY OF RECOMBINANT ChAdOx1 nCoV- 19 CORONA VIRUS VACCINE (COVISHIELD) IN PATIENTS ON HEMODIALYSIS – A PROSPECTIVE, 1-YEAR FOLLOW-UP COHORT STUDY |
| title_fullStr | WCN24-1865 LONG-TERM IMMUNOGENICITY AND EFFICACY OF RECOMBINANT ChAdOx1 nCoV- 19 CORONA VIRUS VACCINE (COVISHIELD) IN PATIENTS ON HEMODIALYSIS – A PROSPECTIVE, 1-YEAR FOLLOW-UP COHORT STUDY |
| title_full_unstemmed | WCN24-1865 LONG-TERM IMMUNOGENICITY AND EFFICACY OF RECOMBINANT ChAdOx1 nCoV- 19 CORONA VIRUS VACCINE (COVISHIELD) IN PATIENTS ON HEMODIALYSIS – A PROSPECTIVE, 1-YEAR FOLLOW-UP COHORT STUDY |
| title_short | WCN24-1865 LONG-TERM IMMUNOGENICITY AND EFFICACY OF RECOMBINANT ChAdOx1 nCoV- 19 CORONA VIRUS VACCINE (COVISHIELD) IN PATIENTS ON HEMODIALYSIS – A PROSPECTIVE, 1-YEAR FOLLOW-UP COHORT STUDY |
| title_sort | wcn24 1865 long term immunogenicity and efficacy of recombinant chadox1 ncov 19 corona virus vaccine covishield in patients on hemodialysis a prospective 1 year follow up cohort study |
| url | http://www.sciencedirect.com/science/article/pii/S2468024924005187 |
| work_keys_str_mv | AT aarthimuthukumaran wcn241865longtermimmunogenicityandefficacyofrecombinantchadox1ncov19coronavirusvaccinecovishieldinpatientsonhemodialysisaprospective1yearfollowupcohortstudy AT jayalakshmiseshadri wcn241865longtermimmunogenicityandefficacyofrecombinantchadox1ncov19coronavirusvaccinecovishieldinpatientsonhemodialysisaprospective1yearfollowupcohortstudy AT ramanswaminathan wcn241865longtermimmunogenicityandefficacyofrecombinantchadox1ncov19coronavirusvaccinecovishieldinpatientsonhemodialysisaprospective1yearfollowupcohortstudy AT mallikaravindran wcn241865longtermimmunogenicityandefficacyofrecombinantchadox1ncov19coronavirusvaccinecovishieldinpatientsonhemodialysisaprospective1yearfollowupcohortstudy |